Clinical studies recruiting near Chapel Hill

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Phase 4 · Chapel Hill · Westat · NCT06738407 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Phase 1/Phase 2 · UNC Hospitals, The University of North Carolina at Chapel Hi · Lin BioScience, Inc · NCT05756322 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 3201, Chapel Hill CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441 Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
NA · University of North Carolina at Chapel Hill, Lineberger Comp · UNC Lineberger Comprehensive Cancer Center · NCT07634653 Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2 · University of North Carolina at Chapel Hill · Darcy Krueger · NCT05104983 Incremental Hemodialysis: The TwoPlus Trial
NA · University of North Carolina Chapel Hill · Wake Forest University Health Sciences · NCT05828823 A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spe
Phase 2 · UNC Chapel Hill · Relay Therapeutics, Inc. · NCT06789913 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · University of North Carolina at Chapel Hill · Ad scientiam · NCT05566769 VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Eva
Phase N/A · University of North Carolina at Chapel Hill · UNC Lineberger Comprehensive Cancer Center · NCT06878547 Apathy in Parkinson Disease TMS Study
NA · UNC-Chapel Hill, Cassidy Lab · University of North Carolina, Chapel Hill · NCT06087926 The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Phase 2 · University of North Carolina at Chapel Hill · Children's Hospital Medical Center, Cincinnati · NCT05538208 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · NC TraCS Institute - CTRC; University of North Carolina at C · Merck Sharp & Dohme LLC · NCT07044297 Connect-Home: Alzheimer's Disease and Related Dementias
NA · University of North Carolina at Chapel Hill · University of North Carolina, Chapel Hill · NCT06840587 Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
Phase 2 · University of North Carolina at Chapel Hill, Department of R · UNC Lineberger Comprehensive Cancer Center · NCT07278557 Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Phase 1/Phase 2 · UNC Hospitals, University of North Carolina at Chapel Hill · Beat AML, LLC · NCT03013998 Integrating New Skills Into Diabetes Education With CGM
NA · University of North Carolina at Chapel Hill · University of North Carolina, Chapel Hill · NCT07463209 Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
NA · University of North Carolina at Chapel Hill · Innova Vascular, Inc. · NCT06041594 Selinexor and Backbone Treatments of Multiple Myeloma Patients
Phase 1/Phase 2 · University of North Carolina - Chapel Hill Comprehensive Can · Karyopharm Therapeutics Inc · NCT02343042 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · NRG Oncology · NCT05946213 Depression, Aging, Stress and Heart Health Study
NA · University of North Carolina at Chapel Hill · University of North Carolina, Chapel Hill · NCT05570721 Stress Trajectories and Anhedonia in Adolescence Research Study
NA · University of North Carolina at Chapel Hill · University of North Carolina, Chapel Hill · NCT07040449 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · UNC Chapel Hill · Novartis Pharmaceuticals · NCT05948943 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · University of North Carolina at Chapel Hill · Duke University · NCT04278404 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · NRG Oncology · NCT06532279 4D-710 in Adult Patients With Cystic Fibrosis
Phase 2 · University of North Carolina at Chapel Hill · 4D Molecular Therapeutics · NCT05248230 Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Phase 4 · University of North Carolina Chapel Hill · Wake Forest University Health Sciences · NCT05421741 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · UNC Lineberger Comprehensive Cancer Center · NRG Oncology · NCT05174169 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · N.C. Children's Hospital - Children's Specialty Clinics - Ch · SAb Biotherapeutics, Inc. · NCT07187531 Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
Phase 4 · University of North Carolina Chapel Hill · Brooke Army Medical Center · NCT06289686 DILIN - Prospective Study
Phase N/A · Univeristy of North Carolina at Chapel Hill · Duke University · NCT00345930

Look up another city

Look up another condition